Log in to save to my catalogue

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patien...

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patien...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ddff242b9c864f39864f3885aee7bad4

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status

About this item

Full title

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status

Publisher

England: BioMed Central Ltd

Journal title

BMC medicine, 2024-01, Vol.22 (1), p.9-9, Article 9

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Due to the abundant usage of chemotherapy in young triple-negative breast cancer (TNBC) patients, the unbiased prognostic value of BRCA1-related biomarkers in this population remains unclear. In addition, whether BRCA1-related biomarkers modify the well-established prognostic value of stromal tumor-infiltrating lymphocytes (sTILs) is unknown. This...

Alternative Titles

Full title

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ddff242b9c864f39864f3885aee7bad4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ddff242b9c864f39864f3885aee7bad4

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-023-03233-7

How to access this item